Adverse drug reactions (ADRs) constitute a significant proportion of hospital admissions globally, with approximately 6.7% attributed to these events. Studies suggest that more than 50% of ADRs could be preventable with cautious prescription practices. The economic burden and strain on healthcare resources associated with managing ADRs are considerable. Despite PvPI efforts, pharmacovigilance remains inadequately practiced due to insufficient understanding and awareness among individuals. This study employed an analytical cross‐sectional approach, utilizing a structured questionnaire administered via Google Forms to randomly selected patients and healthcare workers at Sarojini Naidu Medical College, Agra, India. Participation was voluntary and anonymity was ensured. Data analysis was conducted using Microsoft Excel. The results revealed varying levels of awareness among participants regarding ADRs and Pharmacovigilance. While a majority acknowledged the importance of ADR reporting, a significant proportion lacked knowledge regarding reporting procedures and hesitated to report ADRs. These findings underscore the need for enhanced education and support in this domain. Barriers to ADR reporting identified in this study include inadequate knowledge, time constraints and a lack of confidence among healthcare professionals. Addressing these challenges through regular training sessions and support mechanisms could improve reporting rates and quality. Pharmacovigilance plays a crucial role in ensuring drug safety. Comprehensive training and awareness initiatives are essential to overcome barriers to ADR reporting and enhance pharmacovigilance practices among healthcare professionals and individuals.
Krunal Natvarlal Chauhan and Rahul Kumar Pal. Public Participation in Pharmacovigilance.
DOI: https://doi.org/10.36478/10.59218/makrjms.2024.5.656.659
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2024.5.656.659